FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 95 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q4 2021. The put-call ratio across all filers is 2.12 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,443,000 | +1390.9% | 222,712 | +415.3% | 0.00% | – |
| Q2 2022 | $298,000 | -72.1% | 43,216 | -62.5% | 0.00% | – |
| Q1 2022 | $1,070,000 | +0.9% | 115,125 | +54.5% | 0.00% | – |
| Q4 2021 | $1,060,000 | +109.9% | 74,534 | +242.2% | 0.00% | – |
| Q3 2021 | $505,000 | +155.1% | 21,780 | +173.8% | 0.00% | – |
| Q2 2021 | $198,000 | -85.8% | 7,955 | -84.0% | 0.00% | – |
| Q1 2021 | $1,396,000 | +2151.6% | 49,841 | +2707.9% | 0.00% | – |
| Q4 2020 | $62,000 | +376.9% | 1,775 | +564.8% | 0.00% | – |
| Q3 2020 | $13,000 | -35.0% | 267 | -38.9% | 0.00% | – |
| Q2 2020 | $20,000 | – | 437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,529 | $43,866,000 | 8.09% |
| Logos Global Management LP | 1,410,000 | $39,508,000 | 3.86% |
| RA Capital Management | 9,011,651 | $252,506,000 | 3.81% |
| Cormorant Asset Management, LP | 4,720,000 | $132,254,000 | 2.95% |
| Artal Group S.A. | 1,000,000 | $28,020,000 | 0.50% |
| Perceptive Advisors | 1,250,000 | $35,025,000 | 0.44% |
| HighVista Strategies LLC | 20,630 | $578,000 | 0.43% |
| HHLR ADVISORS, LTD. | 1,100,000 | $30,822,000 | 0.30% |
| Baker Brothers Advisors | 2,024,876 | $56,737,000 | 0.25% |
| Tekla Capital Management LLC | 149,825 | $4,198,000 | 0.14% |